{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:34:54Z","timestamp":1789425294696,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.vaccine.2011.03.038","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T22:03:03Z","timestamp":1302818583000},"page":"3895-3904","source":"Crossref","is-referenced-by-count":93,"title":["A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness"],"prefix":"10.1016","volume":"29","author":[{"given":"V.J.","family":"Gunther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Putnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Eckels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.","family":"Mammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"Sztein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.vaccine.2011.03.038_bib0005","first-page":"311","article-title":"Observations related to pathogenesis of dengue hemorrhagic fever. IV. Relation of disease severity to antibody response and virus recovered","volume":"42","author":"Halstead","year":"1970","journal-title":"Yale J Biol Med"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.038_bib0010","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1128\/JVI.73.5.3623-3629.1999","article-title":"Bystander target cell lysis and cytokine production by dengue virus- specific human CD4(+) cytotoxic T-lymphocyte clones","volume":"73","author":"Gagnon","year":"1999","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.038_bib0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<335::AID-JMV13>3.0.CO;2-E","article-title":"Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures","volume":"59","author":"Chaturvedi","year":"1999","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.038_bib0020","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1034\/j.1399-0039.2002.600405.x","article-title":"HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais","volume":"60","author":"Stephens","year":"2002","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.vaccine.2011.03.038_bib0025","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/JVI.62.11.3928-3933.1988","article-title":"Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells","volume":"62","author":"Kontny","year":"1988","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2011.03.038_bib0030","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JVI.75.8.3501-3508.2001","article-title":"Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis","volume":"75","author":"Libraty","year":"2001","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.038_bib0035","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI115457","article-title":"Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue","volume":"88","author":"Kurane","year":"1991","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.038_bib0040","first-page":"658","article-title":"Human immune responses to dengue viruses","volume":"21","author":"Kurane","year":"1990","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"17","key":"10.1016\/j.vaccine.2011.03.038_bib0045","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1128\/JVI.74.17.7814-7823.2000","article-title":"Infection of human cells by dengue virus is modulated by different cell types and viral strains","volume":"74","author":"Diamond","year":"2000","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.03.038_bib0050","doi-asserted-by":"crossref","first-page":"9729","DOI":"10.1128\/JVI.72.12.9729-9737.1998","article-title":"Study of Dengue virus infection in SCID mice engrafted with human K562 cells","volume":"72","author":"Lin","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0055","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.73.1.783-786.1999","article-title":"New mouse model for dengue virus vaccine testing","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0060","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4269\/ajtmh.1952.1.51","article-title":"Propagation of dengue virus strains in unweaned mice","volume":"1","author":"Meiklejohn","year":"1952","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4269\/ajtmh.1970.19.94","article-title":"Sequential dengue virus infections in the white-handed gibbon (Hylobates lar)","volume":"19","author":"Whitehead","year":"1970","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.038_bib0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4269\/ajtmh.1978.27.590","article-title":"Experimental infection of chimpanzees with dengue viruses","volume":"27","author":"Scherer","year":"1978","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.038_bib0075","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4269\/ajtmh.1958.7.406","article-title":"Experimental infection of New World monkeys with dengue and yellow fever viruses","volume":"7","author":"Rosen","year":"1958","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.03.038_bib0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0035-9203(85)90348-7","article-title":"Quantity of dengue virus required to infect rhesus monkeys","volume":"79","author":"Kraiselburd","year":"1985","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/infdis\/128.1.15","article-title":"Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0090","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/128.1.7","article-title":"Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection","volume":"128","author":"Halstead","year":"1973","journal-title":"J Infect Dis"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2011.03.038_bib0095","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4269\/ajtmh.2003.69.12","article-title":"Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys","volume":"69","author":"Eckels","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2011.03.038_bib0100","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024","article-title":"Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates","volume":"69","author":"Sun","year":"2003","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2011.03.038_bib0105","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/infdis\/170.6.1448","article-title":"A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans","volume":"170","author":"Edelman","year":"1994","journal-title":"J Infect Dis"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2011.03.038_bib0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2003.69.48","article-title":"Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine","volume":"69","author":"Edelman","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.vaccine.2011.03.038_bib0115","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1086\/503372","article-title":"Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination","volume":"193","author":"Sun","year":"2006","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.038_bib0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/jcu.20476","article-title":"Sonographic findings of healthy volunteers infected with dengue virus","volume":"36","author":"Statler","year":"2008","journal-title":"J Clin Ultrasound"},{"issue":"12","key":"10.1016\/j.vaccine.2011.03.038_bib0125","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1086\/340822","article-title":"Cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren","volume":"185","author":"Mangada","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.03.038_bib0130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/infdis\/4.3.440","article-title":"Experimental investigations regarding the etiology of dengue fever","volume":"4","author":"Ashburn","year":"1907","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.038_bib0135","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S0022172400007476","article-title":"Further experiments in the etiology of dengue fever","volume":"18","author":"Cleland","year":"1919","journal-title":"J Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/90.1.1","article-title":"Experimental studies on dengue. I. Isolation, identification and modification of the virus","volume":"90","author":"Hotta","year":"1952","journal-title":"J Infect Dis"},{"issue":"2634","key":"10.1016\/j.vaccine.2011.03.038_bib0145","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.101.2634.640","article-title":"Production of immunity to dengue with virus modified by propagation in mice","volume":"101","author":"Sabin","year":"1945","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.038_bib0150","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4049\/jimmunol.77.5.352","article-title":"Clinical and serologic response of man to immunization with attnuated dengue and yellow fever viruses","volume":"77","author":"Schlesinger","year":"1956","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2011.03.038_bib0155","first-page":"204","article-title":"Dengue: a study of its mode of propagation and pathology","volume":"61","author":"Graham","year":"1902","journal-title":"Med Rec New york"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.038_bib0160","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1086\/314680","article-title":"Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity","volume":"179","author":"Green","year":"1999","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.038_bib0165","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1078\/0171-2985-00058","article-title":"Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever","volume":"204","author":"Azeredo","year":"2001","journal-title":"Immunobiology"},{"issue":"6","key":"10.1016\/j.vaccine.2011.03.038_bib0170","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cyto.2004.05.007","article-title":"Systemic host inflammatory and coagulation response in the Dengue virus primo-infection","volume":"27","author":"Avila-Aguero","year":"2004","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.038_bib0175","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1086\/517807","article-title":"Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever","volume":"177","author":"Bethell","year":"1998","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.038_bib0180","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1590\/S0074-02762001000200015","article-title":"Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever","volume":"96","author":"Braga","year":"2001","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.038_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00758172","article-title":"Activation via TCR or IL-2 receptor of a CD8+ suppressor T cell clone: effect on IL-10 production and on proliferation of the suppressor T cell","volume":"14","author":"Minai","year":"1994","journal-title":"Cytotechnology"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.038_bib0190","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.4049\/jimmunol.149.7.2378","article-title":"IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells","volume":"149","author":"Yssel","year":"1992","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.038_bib0195","doi-asserted-by":"crossref","first-page":"753","DOI":"10.4049\/jimmunol.162.2.753","article-title":"A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB\/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice","volume":"162","author":"Gabaglia","year":"1999","journal-title":"J Immunol"},{"issue":"5405","key":"10.1016\/j.vaccine.2011.03.038_bib0200","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1126\/science.283.5405.1183","article-title":"Reciprocal control of T helper cell and dendritic cell differentiation [see comments]","volume":"283","author":"Rissoan","year":"1999","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0205","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cytogfr.2003.11.001","article-title":"The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle","volume":"15","author":"Mocellin","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.038_bib0210","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.4049\/jimmunol.151.9.4545","article-title":"Human IL-10 is a chemoattractant for CD8+ T lymphocytes and an inhibitor of IL-8-induced CD4+ T lymphocyte migration","volume":"151","author":"Jinquan","year":"1993","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.03.038_bib0215","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1084\/jem.184.3.821","article-title":"Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells","volume":"184","author":"Vora","year":"1996","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.vaccine.2011.03.038_bib0220","doi-asserted-by":"crossref","first-page":"4729","DOI":"10.1128\/JVI.74.10.4729-4737.2000","article-title":"Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes","volume":"74","author":"Santin","year":"2000","journal-title":"J Virol"},{"issue":"2 (Suppl. 1)","key":"10.1016\/j.vaccine.2011.03.038_bib0225","first-page":"10","article-title":"Interferon-gamma prototype of the proinflammatory cytokines\u2014importance in activation, suppression, and maintenance of the immune response","volume":"25","author":"Halloran","year":"1993","journal-title":"Transplant Proc"},{"issue":"9","key":"10.1016\/j.vaccine.2011.03.038_bib0230","first-page":"642","article-title":"Gamma-interferon: an immunoregulatory lymphokine with immunotherapeutic potential","volume":"9","author":"Lewis","year":"1990","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0235","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.181.1.423","article-title":"CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE","volume":"181","author":"Paganelli","year":"1995","journal-title":"J Exp Med"},{"issue":"8","key":"10.1016\/j.vaccine.2011.03.038_bib0240","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1073\/pnas.90.8.3725","article-title":"Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist","volume":"90","author":"Tripp","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.038_bib0245","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-1759(89)90159-2","article-title":"Isolation of encephalitogenic CD4+ T cell clones in the rat. Cloning methodology and interferon-gamma secretion","volume":"121","author":"Sedgwick","year":"1989","journal-title":"J Immunol Methods"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.038_bib0250","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/IAI.18.2.283-290.1977","article-title":"Cellular source of interferons in the circulation of mice with delayed hypersensitivity","volume":"18","author":"Sonnenfeld","year":"1977","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/(SICI)1096-9896(199709)183:1<105::AID-PATH1094>3.0.CO;2-E","article-title":"Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3","volume":"183","author":"Seko","year":"1997","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.03.038_bib0260","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1006\/viro.1994.1324","article-title":"Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma)","volume":"202","author":"Smith","year":"1994","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2011.03.038_bib0265","first-page":"113","article-title":"Interleukin-2, interferon-gamma and natural killer cell activity in bronchoalveolar lavage fluid from marrow transplant recipients with cytomegalovirus pneumonia","volume":"11","author":"Slavin","year":"1993","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.vaccine.2011.03.038_bib0270","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0171-2985(11)80089-6","article-title":"In vivo depletion of interferon-gamma leads to susceptibility of A\/J mice to mouse hepatitis virus 3 infection","volume":"185","author":"Lucchiari","year":"1992","journal-title":"Immunobiology"},{"issue":"122","key":"10.1016\/j.vaccine.2011.03.038_bib0275","first-page":"24","article-title":"Immunological enhancement of dengue virus replication","volume":"243","author":"Halstead","year":"1973","journal-title":"Nature New Biol"},{"issue":"7","key":"10.1016\/j.vaccine.2011.03.038_bib0280","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nm887","article-title":"Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever","volume":"9","author":"Mongkolsapaya","year":"2003","journal-title":"Nat Med"},{"issue":"13","key":"10.1016\/j.vaccine.2011.03.038_bib0285","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Munoz-Jordan","year":"2005","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.03.038_bib0290","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1365-2567.2006.02397.x","article-title":"Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cells","volume":"118","author":"Chichester","year":"2006","journal-title":"Immunology"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11004063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:44:40Z","timestamp":1712378680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11004063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":58,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S0264410X11004063"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.03.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}